Learn more

CELLULAR BIOMEDICINE GROUP SHANGHAI LTD

Overview
  • Total Patents
    27
  • GoodIP Patent Rank
    66,990
  • Filing trend
    ⇧ 50.0%
About

CELLULAR BIOMEDICINE GROUP SHANGHAI LTD has a total of 27 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are DEISSEROTH ALBERT B, PSIOXUS THERAPEUTICS LTD and VIROGIN BIOTECH CANADA LTD.

Patent filings per year

Chart showing CELLULAR BIOMEDICINE GROUP SHANGHAI LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhang Li 17
#2 He Jiaping 16
#3 Wang Fei 11
#4 Cao Wei 9
#5 Li Zhiyuan 6
#6 Zhu Wei 6
#7 Yao Xin 6
#8 Wang Qingxia 6
#9 Yao Yihong 6
#10 Huang Jiaqi 6

Latest patents

Publication Filing date Title
WO2018214942A1 Cell cryopreservation kit
KR20200073171A Cell cryopreservation agent and cell regeneration method
WO2018068766A1 Cd19-targeted chimeric antigen receptor, and preparation method and application thereof
CN108395482A A kind of activity identification of targeting CD20 antigen Chimeric antigen receptors built and its be engineered T cell
CN108395481A A kind of activity identification of the CAR of targeting CD20 built and its be engineered T cell
CN108235981A It is a kind of can Clinical practice cells frozen storing liquid
CN107427558A Treat the composition of articular cartilage defect
WO2016116035A1 Cd30-targeted chimeric antigen receptor and nkt cell and preparation method therefor and application thereof
WO2016078616A1 Adipose mesenchymal progenitor cell and adipose stromal vascular fraction composition used for treating hepatitis b
WO2016029855A1 Her1-targeted chimeric antigen receptor and nkt cell as well as preparation method therefor and application thereof
AU2014211790A1 Use of allogeneic interstitial vessel-layer cell and allogeneic mesenchymal progenitor cell for preventing or treating osteoarthritis
WO2014090111A1 Use of stromal vascular fraction cells and mesenchymal progenitor cells for prevention or treatment of rheumatoid arthritis
WO2014075634A1 Use of stromal vascular layer cell and mesenchymal progenitor cell for preventing or treating osteoarthritis
EP2807923A1 Serum-free freezing medium comprising high content of ksr and establishment of adipose-derived stem cell library